SarojVadhan-RajMD

Oncology • Houston, TX

Physician

Join to view full profile

Are you Dr. Vadhan-Raj?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 16 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161
Is this information wrong?

Summary

Dr. Saroj Vadhan-Raj, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Florida, and Maryland. She is affiliated with University of Texas M.D. Anderson Cancer Center.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
Memorial Sloan Kettering Cancer CenterImmunology, 1982 - 1985
Brooklyn Hospital CenterResidency, Internal Medicine, 1979 - 1982
Grant Medical CollegeClass of 1978

Certifications & Licensure

FL State Medical License 2021 - Present
TX State Medical License 1986 - 2025
MD State Medical License 1981 - 1987
American Board of Internal Medicine Internal Medicine

Clinical Trials

rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin Start of enrollment: 1999 Jul 23
Completed
Not Applicable
A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients Start of enrollment: 2001 Oct 31
Terminated
Phase 3
Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy Start of enrollment: 2001 Jun 01
Completed
Phase 3
Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide Start of enrollment: 2003 Jun 02
Completed
Not Applicable
Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma Start of enrollment: 2006 Mar 01
Completed
Phase 1, Phase 2
Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS Start of enrollment: 2006 Jul 01
Completed
Phase 1, Phase 2
Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) Start of enrollment: 2006 Dec 01
Completed
Not Applicable
Voraxaze for Delayed Methotrexate Clearance Start of enrollment: 2007 Jan 01
Terminated
Phase 1, Phase 2
Rasburicase in Patients at Risk for Tumor Lysis Syndrome Start of enrollment: 2008 Jan 01
Completed
Phase 2
Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients Start of enrollment: 2008 Mar 01
Completed
Not Applicable
Caphosol in Sarcoma Patients With Mucositis Start of enrollment: 2010 Apr 01
Completed
Phase 2
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients Start of enrollment: 2010 Apr 01
Completed
Phase 4
Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 Start of enrollment: 2011 Apr 01
Completed
Phase 2
Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy Start of enrollment: 2016 Oct 12
Terminated
Phase 2
Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy Start of enrollment: 2017 Dec 18
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

20 citations
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study
Saroj Vadhan-Raj, Mairéad G McNamara, Marino Venerito, Hanno Riess, Eileen M. O'Reilly, Michael J. Overman, Xiao Zhou, Ujjwala Vijapurkar, Simrati Kaul, Peter Wildgoos...> ;Cancer Medicine. 2019 May 26
39 citations
A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer
Morten Schiødt, Saroj Vadhan-Raj, Mark S. Chambers, Ourania Nicolatou-Galitis, Constantinus Politis, Ruxandra Coropciuc, Stefano Fedele, Danielle Jandial, Jeffrey Zhan...> ;Supportive Care in Cancer. 2018 Jun 1
7 citations
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer.
Saroj Vadhan-Raj, Naomi V. Dahl, Kristine Bernard, Zhu Li, William Strauss> ;Journal of Blood Medicine. 2017 Dec 7
89 citations
Myeloid growth factors, version 2.2017
Jeffrey Crawford, Pamela S. Becker, James O. Armitage, Douglas W. Blayney, Julio C. Chavez, Peter T. Curtin, Shira Dinner, Thomas Fynan, Ivana Gojo, Elizabeth A. Griff...> ;Journal of the National Comprehensive Cancer Network. 2017 Dec 1
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial.
Khorana, A. A.,Vadhan-Raj, S.,Kuderer, N. M.,Wun, T.,Liebman, H.,Soff, G.,Belani, C.,O'Reilly, E. M.,McBane, R.,Eikelboom, J.,Damaraju, C. V.,Beyers, K.,Dietrich, F.,K...> ;Thromb. Haemost.. 2017 Dec 05
3 citations
Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion.
Raymundo A. Quintana, Jose Banchs, Ridhi Gupta, Heather Lin, Sean D. Raj, Anthony P. Conley, Vinod Ravi, Dejka M. Araujo, Robert S. Benjamin, Shreyaskumar Patel, Saroj...> ;Sarcoma. 2017 Sep 26
48 citations
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia.
Saroj Vadhan-Raj, Rafat Abonour, Jonathan W. Goldman, David Smith, Christopher A. Slapak, Robert Ilaria, Ramon V. Tiu, Xuejing Wang, Sophie Callies, Joanne Cox, Jay Tu...> ;Journal of Hematology & Oncology. 2017 Mar 21
47 citations
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial
Alok A. Khorana, Saroj Vadhan-Raj, Nicole M. Kuderer, Theodore Wun, Howard A. Liebman, Gerald A. Soff, Chandra P. Belani, Eileen M. O'Reilly, Robert D. McBane, John W....> ;Thrombosis and Haemostasis. 2017 Nov 1
8 citations
Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a ph...
Saroj Vadhan-Raj, David C. Ford, Naomi V. Dahl, Kristine Bernard, Zhu Li, Lee F. Allen, William Strauss> ;American Journal of Hematology. 2016 Feb 1
37 citations
Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial
Noopur Raje, Saroj Vadhan-Raj, Wolfgang Willenbacher, E. Terpos, Vania Hungria, Andrew Spencer, Y Alexeeva, Thierry Facon, Alexander Keith Stewart, Amy Feng, Ada Braun...> ;Blood Cancer Journal. 2016 Jan 8
78 citations
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics
Allan Lipton, Karim Fizazi, Alison Stopeck, David H. Henry, Matthew R. Smith, N. Shore, Miguel Martin, Saroj Vadhan-Raj, Janet E. Brown, Gary Richardson, Fred Saad, De...> ;European Journal of Cancer. 2016 Jan 1
16 citations
ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer.
Donghui Li, Mayurika N Pise, Michael J. Overman, Chang Liu, Hong Wei Tang, Saroj Vadhan-Raj, James L. Abbruzzese> ;Cancer Medicine. 2015 Nov 1
34 citations
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease
Ingo Diel, Jean-Jacques Body, Alison Stopeck, Saroj Vadhan-Raj, Andrew Spencer, Günther G. Steger, Roger von Moos, François Goldwasser, Amy Feng, Ada Braun> ;European Journal of Cancer. 2015 Jul 1
112 citations
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients ...
David H. Henry, Saroj Vadhan-Raj, Vera Hirsh, Roger von Moos, Vania Hungria, Luis Costa, Penella J. Woll, Giorgio V. Scagliotti, Geoffrey Smith, Amy Feng, Susie Jun, R...> ;Supportive Care in Cancer. 2014 Mar 1
60 citations
Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron
Saroj Vadhan-Raj, William Strauss, David C. Ford, Kristine Bernard, Ralph V. Boccia, Joe Li, Lee F. Allen> ;American Journal of Hematology. 2014 Jan 1
43 citations
Clinical applications of palifermin: Amelioration of oral mucositis and other potential indications
Saroj Vadhan-Raj, Jenna D. Goldberg, Miguel-Angel Perales, Dietmar Berger, Marcel R.M. van den Brink> ;Journal of Cellular and Molecular Medicine. 2013 Nov 1
118 citations
Myeloid growth factors.
Jeffrey Crawford, James Armitage, Lodovico Balducci, Pamela Sue Becker, Douglas W Blayney, Spero R Cataland, Mark L Heaney, Susan Hudock, Dwight D Kloth, David J Kuter...> ;Journal of the National Comprehensive Cancer Network. 2013 Oct 1
15 citations
Prognostic significance of elevated D-dimer for survival in patients with sarcoma.
Sean D. Raj, Xiao Zhou, Carlos E. Bueso-Ramos, Vinod Ravi, Shreyaskumar Patel, Robert S. Benjamin, Saroj Vadhan-Raj> ;American Journal of Clinical Oncology. 2012 Oct 1
5 citations
Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11.
Rashmi Kanagal-Shamanna, Weiqiang Zhao, Saroj Vadhan-Raj, Martin Nguyen, Michael Fernandez, L. Jeffrey Medeiros, Carlos E. Bueso-Ramos> ;International Journal of Environmental Research and Public Health. 2012 Aug 1
34 citations
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid
Saroj Vadhan-Raj, R. von Moos, Lesley Fallowfield, Donald L. Patrick, François Goldwasser, Charles S. Cleeland, David H. Henry, Silvia Novello, Vania Tm Hungria, Yi Qi...> ;Annals of Oncology. 2012 Dec 1
57 citations
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome
Saroj Vadhan-Raj, Luis Fayad, Michelle A. Fanale, Barbara Pro, Alma Rodriguez, Fredrick B. Hagemeister, C. E. Bueso-Ramos, Xiao Zhou, P. McLaughlin, Nathan Fowler, Jat...> ;Annals of Oncology. 2012 Jun 1
59 citations
Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leuk...
Rashmi Kanagal-Shamanna, Carlos E. Bueso-Ramos, Bedia A. Barkoh, Gary Lu, Sa Wang, Guillermo Garcia-Manero, Saroj Vadhan-Raj, Daniela Hoehn, L. Jeffrey Medeiros, C. Ca...> ;Cancer. 2012 Jun 1
19 citations
Phase III Randomized Trial of Dose Intensive Neoadjuvant Chemotherapy with or Without G-CSF in Locally Advanced Breast Cancer: Long-Term Results
Banu Arun, Kapil Dhinghra, Vicente Valero, Shu Wan Kau, Kristine Broglio, Daniel J. Booser, Laura Guerra, Guosheng Yin, Ronald S. Walters, Aysegul Sahin, Nuhad K. Ibra...> ;The Oncologist. 2011 Nov 1
Myeloid growth factors.
Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Steensma DP, Vadhan-Raj S, Westervelt P...> ;J Natl Compr Canc Netw. 2011-08-01
839 citations
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate ...
David H. Henry, Luis Costa, François Goldwasser, Vera Hirsh, Vania Hungria, Jana Prausova, Giorgio V. Scagliotti, Harm Sleeboom, Andrew Spencer, Saroj Vadhan-Raj, Roge...> ;Journal of Clinical Oncology. 2011 Mar 20
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

University of Texas M.D. Anderson Cancer CenterHouston, Texas